Male Infertility

Difficulty conceiving is one of the most emotionally painful challenges a couple can face — and it is far more common than most people realize. About one in seven couples struggles with infertility, and when the cause is investigated, the male partner is a contributing factor roughly half the time. Male infertility is not a reflection of masculinity or sexual health; it is a medical condition with identifiable causes, most of which are treatable. This page explains what we know, what can be tested, and what options exist.

1. Overview

Male infertility is defined as the inability of a couple to achieve pregnancy after at least 12 months of regular, unprotected intercourse, where the cause is attributable (fully or in part) to the male partner. It is not a single condition but a cluster of underlying problems — hormonal, anatomical, genetic, or environmental — that impair sperm production, function, or delivery.

How Common Is It?

About 7% of all adult males are affected by infertility. When an infertile couple is evaluated:

Yet male infertility remains underdiagnosed. Cultural stigma, lack of awareness, and the assumption that "the problem is with her" all delay evaluation. A simple semen analysis — the cornerstone of male fertility testing — can be done quickly and is the logical first step alongside female evaluation.

Emotional Weight

Receiving a diagnosis of male infertility can be devastating. Many men feel shame, guilt, or a sense of failure that has nothing to do with the biology. It is worth saying plainly: infertility is not a character flaw, not a punishment, and not permanent in most cases. It is a medical problem, and medicine has a great deal to offer.

↑ Back to Table of Contents

2. Semen Analysis — the Foundation of Diagnosis

A semen analysis is the first and most important test in male fertility evaluation. It is performed on a sample collected after 2–7 days of sexual abstinence. Because semen quality varies from sample to sample, at least two analyses separated by several weeks are recommended before drawing conclusions.

WHO 2021 Reference Values

The World Health Organization's 6th edition laboratory manual (2021) provides the current standard reference values, derived from fertile men whose partners conceived within 12 months:

These are the 5th percentile thresholds — not "ideal" values, but the lower boundary seen in men who are fertile. A result below any threshold warrants further investigation.

Key Terminology

What the Numbers Mean in Practice

An abnormal semen analysis does not mean pregnancy is impossible — it means the chances are lower per cycle. Even men with severe oligospermia can father children naturally or with assistance. Conversely, a "normal" semen analysis does not guarantee fertility, because standard analysis does not capture sperm DNA fragmentation, functional capacity, or genetic integrity. Semen analysis is the starting point, not the whole answer.

↑ Back to Table of Contents

3. Causes: Pretesticular (Hormonal)

Pretesticular causes account for about 5–10% of male infertility. The testes are structurally normal, but the hormonal signals that drive spermatogenesis — particularly FSH and LH from the pituitary gland — are absent or insufficient. The testes cannot produce sperm without these signals, no matter how healthy the testicular tissue.

Hypogonadotropic Hypogonadism (HH)

The defining condition. Low FSH and LH → low testosterone → impaired spermatogenesis. Causes include:

Anabolic Steroid Abuse

This is a very common and frequently underreported cause. Exogenous testosterone and anabolic steroids — whether prescribed or self-administered — profoundly suppress LH and FSH through negative feedback on the hypothalamus and pituitary. The result is testicular atrophy and azoospermia. Men often do not volunteer this history. The good news: suppression is usually reversible after stopping steroids, though recovery may take 6–18 months or longer depending on duration and dose of use.

Obesity

Adipose tissue contains aromatase, the enzyme that converts testosterone to estrogen. Obese men have elevated estrogen levels, which feedback-suppress LH and FSH and reduce spermatogenesis. Significant weight loss can improve hormonal profiles and semen parameters.

Thyroid Disease

Both hypothyroidism and hyperthyroidism can impair spermatogenesis. Thyroid hormones regulate Sertoli cell function and sperm maturation. Treatment of thyroid disease often improves fertility.

↑ Back to Table of Contents

4. Causes: Testicular

Testicular (or "primary") causes are the largest category, accounting for 65–80% of male infertility. The signal from the brain may be normal, but the testes themselves cannot produce adequate numbers of healthy sperm.

Varicocele — the Most Common Correctable Cause

A varicocele is an abnormal dilation of the veins draining the testis (the pampiniform plexus), similar to varicose veins in the legs. It occurs in about 15% of all men but in approximately 35–40% of infertile men — a striking difference that reflects its causal role.

The leading mechanism is elevated scrotal temperature: varicocele veins pool warm blood that would normally be cooled as it flows away from the testes, and spermatogenesis is exquisitely temperature-sensitive (the reason the testes are outside the body in the first place). Oxidative stress from blood stasis is a second mechanism.

Varicoceles are graded 1 through 3 by size (Grade 3 being the largest, visible to the naked eye). For men with a Grade 2 or 3 varicocele and an abnormal semen analysis (whose female partner has reasonable fertility), varicocelectomy — surgical ligation of the abnormal veins — has been shown to improve sperm parameters and live birth rates. Microsurgical varicocelectomy (subinguinal approach) provides the best outcomes with the lowest recurrence and complication rates.

Cryptorchidism (Undescended Testis)

During fetal development, the testes descend from the abdomen into the scrotum. When one or both testes fail to descend — cryptorchidism — the warmer intra-abdominal temperature impairs spermatogenesis. Bilateral cryptorchidism causes severe impairment; unilateral has a lesser but real effect.

Surgical correction (orchiopexy) should ideally be performed before age 2, when Leydig cell and Sertoli cell function are most critical to long-term testicular development. Orchiopexy after age 2 still reduces (but does not eliminate) the risk of infertility and testicular cancer.

Mumps Orchitis

Mumps infection after puberty can cause orchitis (testicular inflammation) in up to 30% of cases, and bilateral orchitis can lead to permanent testicular damage and impaired spermatogenesis. Vaccination (MMR) prevents this.

Testicular Torsion with Infarction

If testicular torsion is not corrected within 6 hours, irreversible ischemic damage occurs. Even unilateral torsion can impair sperm production in the affected and — through immunological mechanisms — sometimes the contralateral testis.

Radiation and Chemotherapy

Both can permanently damage the germinal epithelium. The severity depends on dose and agents (alkylating agents such as cyclophosphamide are particularly gonadotoxic). Men planning cancer treatment should be offered sperm banking before therapy.

Sertoli-Cell-Only Syndrome and Maturation Arrest

In Sertoli-cell-only syndrome, the testes contain supporting Sertoli cells but no germ cells — no sperm-producing cells at all. Testicular biopsy shows tubules lined with Sertoli cells and nothing else. Maturation arrest is a related condition in which germ cells are present but stop developing at a specific stage. Both can be idiopathic or caused by genetic factors.

Idiopathic Infertility

A substantial portion of men with abnormal semen parameters have no identifiable cause after thorough evaluation. This is labeled "idiopathic" and likely reflects a mix of undiscovered genetic factors, environmental exposures, and stochastic variation in spermatogenesis.

↑ Back to Table of Contents

5. Causes: Post-testicular (Obstruction)

Post-testicular causes account for about 10–20% of male infertility. The testes are producing sperm normally, but the sperm cannot reach the ejaculate because of an obstruction or a problem with ejaculation. This is an important distinction: obstructive azoospermia carries an excellent prognosis for sperm retrieval and successful assisted reproduction.

Vasectomy

The most common intentional cause of obstructive azoospermia. Vasectomy reversal (vasovasostomy) has the highest success rates when performed within 3 years of the original vasectomy (patency rates above 90%). After 15 or more years, success rates fall significantly, likely due to secondary epididymal obstruction and antisperm antibody formation. Sperm retrieval with ICSI is an alternative when reversal is not feasible or has failed.

Congenital Bilateral Absence of the Vas Deferens (CBAVD)

Some men are born without the vas deferens — the tube that carries sperm from the epididymis to the urethra. This is often the only sign of underlying CFTR gene mutations. About 80% of men with CBAVD carry at least one CFTR mutation, even if they have no symptoms of cystic fibrosis. Low semen volume and absent sperm are the characteristic findings. Sperm can typically be retrieved directly from the epididymis (MESA) for use with ICSI. Genetic counseling is essential before treatment, since the female partner should be screened for CFTR carrier status.

Epididymal Obstruction

The epididymis — the coiled tube where sperm mature — can become obstructed after sexually transmitted infections (particularly chlamydia and gonorrhea causing epididymitis), prior surgery, or trauma. Reconstructive microsurgery (epididymovasostomy) can restore patency in selected cases.

Ejaculatory Duct Obstruction

Blockage of the ejaculatory ducts where they enter the urethra causes low-volume, fructose-negative azoospermia. Causes include midline cysts, post-infectious scarring, and calcification. Transurethral resection of the ejaculatory ducts (TURED) can relieve obstruction in some cases.

Retrograde Ejaculation

Instead of being propelled forward through the urethra, semen travels backward into the bladder during orgasm. Common causes include: diabetes (autonomic neuropathy), alpha-blocker medications (used for benign prostatic hyperplasia), spinal cord injury, and transurethral resection of the prostate (TURP). Diagnosis is confirmed by finding sperm in a post-ejaculate urine sample. Sperm can be harvested from the bladder urine for intrauterine insemination in many cases.

↑ Back to Table of Contents

6. Genetic Causes

Genetic abnormalities are found in 15–30% of men with azoospermia and in a smaller but significant proportion of men with severe oligospermia. Genetic testing is a standard part of the workup for these men, not only to guide treatment but also to counsel about inheritance risks.

Y Chromosome Microdeletions

The long arm of the Y chromosome contains three regions critical for spermatogenesis, called the Azoospermia Factor (AZF) regions — AZFa, AZFb, and AZFc. Microdeletions in these regions cause varying degrees of impairment:

Klinefelter Syndrome (47,XXY)

Klinefelter syndrome is the most common sex chromosome abnormality and the most common genetic cause of azoospermia, occurring in approximately 1 in 660 males. The extra X chromosome disrupts spermatogenesis, resulting in small testes, azoospermia, and often gynecomastia. Testosterone is typically low, and FSH is markedly elevated.

Despite azoospermia in the ejaculate, focal areas of active spermatogenesis may remain in the testes. Microdissection TESE (micro-TESE) — a microsurgical technique that identifies and harvests these islands of sperm production — finds usable sperm in approximately 50% of men with Klinefelter syndrome. Those sperm can be used for ICSI.

CFTR Mutations

As noted above, CFTR mutations cause CBAVD. A man with CBAVD and a female partner who is a CFTR carrier has a 25% chance per pregnancy of having a child with cystic fibrosis. Preimplantation genetic testing of embryos (PGT) can avoid this.

↑ Back to Table of Contents

7. Lifestyle and Environmental Factors

Lifestyle factors are modifiable contributors — not always the primary cause, but ones that can meaningfully improve or worsen sperm quality. Addressing them is a reasonable first step for any man concerned about fertility, and they cost nothing to change.

Anabolic Steroids

Mentioned under hormonal causes but worth repeating here: this is the single most impactful modifiable cause of male infertility in young men. Even modest doses suppress gonadotropins to levels that cause azoospermia. Recovery after cessation is usually complete but can take 6–18 months or longer with heavy, prolonged use.

Heat Exposure

Spermatogenesis requires a scrotal temperature approximately 2–4°C below core body temperature. Frequent hot tub or sauna use, prolonged laptop use on the lap, and consistently tight underwear are commonly cited — the evidence for each is real but modest in magnitude. The effect is reversible: stopping the exposure for 2–3 months typically allows recovery.

Recreational Drugs and Alcohol

Cannabis (THC) has been shown to reduce sperm motility and may alter sperm morphology. Heavy alcohol use reduces testosterone and impairs sperm production. Cocaine has been associated with impaired sperm motility. These effects are generally reversible with cessation.

Smoking

Cigarette smoking generates oxidative stress that damages sperm DNA. Men who smoke have lower sperm counts, motility, and morphology than non-smokers. Sperm DNA fragmentation — a marker of genetic integrity not captured by standard semen analysis — is consistently elevated in smokers.

Obesity

Via the aromatase mechanism described earlier, obesity both reduces testosterone and increases scrotal temperature (from fat deposition around the scrotum). Weight loss improves semen parameters in obese men.

Endocrine-Disrupting Chemicals

Bisphenol A (BPA), phthalates (found in plastics and personal care products), and pesticides are known endocrine disruptors. Epidemiological studies have raised concern about their effects on sperm quality, particularly in occupationally exposed populations. Reducing exposure — using glass or stainless steel food containers, avoiding microwaving plastics — is a reasonable precaution, though the individual benefit is difficult to quantify.

Age

Unlike women, men continue producing sperm throughout life. However, sperm DNA fragmentation increases with age, and advanced paternal age (generally defined as above 40–45) is associated with increased rates of certain genetic conditions in offspring. Fertility may still be achievable, but the quality of sperm — particularly DNA integrity — declines over decades.

↑ Back to Table of Contents

8. Diagnosis and Workup

The workup for male infertility is systematic and builds from simple tests to more specialized investigations, guided by the results at each step.

Initial Evaluation

Hormonal Panel

For any man with abnormal semen analysis or suspected endocrine cause:

Genetic Testing

Indicated for azoospermia or severe oligospermia (typically below 5 million/mL):

Imaging

Additional Tests

↑ Back to Table of Contents

9. Treatment

Treatment depends entirely on the underlying cause — which is why diagnosis matters. The good news is that most causes have a specific and effective treatment pathway.

Varicocelectomy

Microsurgical varicocelectomy (subinguinal approach) is the treatment of choice for men with a clinically significant varicocele (Grade 2–3) and abnormal semen parameters, provided the female partner has reasonable fertility potential. Multiple randomized trials and meta-analyses confirm improved sperm concentration, motility, and — most importantly — live birth rates after repair. The subinguinal microsurgical approach minimizes recurrence and hydrocele formation compared to open inguinal or laparoscopic approaches.

Hormonal Treatment for Hypogonadotropic Hypogonadism

For men whose infertility is caused by low FSH and LH (not primary testicular failure), gonadotropin therapy is highly effective:

In men with hypogonadotropic hypogonadism, this combination achieves pregnancy rates above 80% — making it one of the most effective treatments in all of reproductive medicine. Treatment typically takes 12–24 months to achieve full spermatogenesis.

Clomiphene and Letrozole (Empirical)

Clomiphene citrate (a selective estrogen receptor modulator) and letrozole (an aromatase inhibitor) can modestly increase endogenous testosterone and gonadotropin secretion in eugonadal infertile men. The evidence is weaker than for direct gonadotropin therapy, and these agents are used off-label. They are most useful in men with low-normal testosterone and idiopathic oligospermia.

Vasectomy Reversal

Vasovasostomy (re-anastomosis of the vas deferens) is the definitive treatment when obstructive azoospermia is caused by vasectomy. Patency rates exceed 90% when performed within 3 years of vasectomy; rates decline to about 75% at 3–8 years and lower beyond 15 years. Pregnancy rates depend on female partner age and fertility. Microsurgical reversal is strongly preferred; non-microsurgical approaches have markedly lower success.

Sperm Retrieval for Obstructive Azoospermia

When reversal is not possible or has failed, sperm can be retrieved directly for use with in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI):

Sperm Retrieval for Non-Obstructive Azoospermia

When to Involve a Reproductive Endocrinologist and Urologist

Male infertility evaluation and treatment is ideally a collaboration between a reproductive urologist (for surgical interventions) and a reproductive endocrinologist (for ART coordination and female partner evaluation). Couples should not wait years before seeking evaluation — particularly if the woman is over 35, when female age-related fertility decline becomes a significant factor.

↑ Back to Table of Contents

10. Assisted Reproductive Technologies

When natural conception is not achievable, assisted reproductive technologies (ART) allow sperm — even in very small numbers — to fertilize eggs and achieve pregnancy. These techniques have transformed the prognosis for men with even the most severe forms of infertility.

Intrauterine Insemination (IUI)

Washed, concentrated sperm are placed directly into the uterus around the time of ovulation. IUI is appropriate for mild male factor infertility (low-normal semen parameters) or cervical factor. It requires a sufficient number of motile sperm (typically ≥5–10 million total motile sperm after washing) and open fallopian tubes in the female partner. Success rates per cycle are modest (10–20%), and multiple cycles are usually attempted.

In Vitro Fertilization (IVF)

Eggs are retrieved from the female partner after ovarian stimulation, fertilized in the laboratory, and the resulting embryos are transferred to the uterus. IVF bypasses many of the barriers that impair natural fertilization. It is indicated for more severe male factor when IUI has failed or is not feasible.

Intracytoplasmic Sperm Injection (ICSI)

A single sperm is injected directly into a single egg using a microscopic needle. ICSI is the breakthrough that made IVF possible for men with azoospermia — because even a handful of sperm retrieved from the epididymis or testis are sufficient. ICSI is now used in the majority of IVF cycles worldwide and is the essential partner to surgical sperm retrieval (MESA, TESE, micro-TESE).

ICSI does not fully overcome sperm DNA fragmentation or genetic abnormalities, which is why genetic testing (karyotype, Y microdeletion, CFTR) remains important even when ICSI is planned.

Preimplantation Genetic Testing (PGT)

For couples where the male carries a genetic abnormality (Y microdeletion, CFTR carrier, chromosomal rearrangement), embryos can be biopsied before transfer and tested to select unaffected embryos. PGT-A (aneuploidy testing) also screens for chromosomal number errors, which is particularly useful with sperm from men with Klinefelter syndrome where the risk of chromosomally abnormal embryos is elevated.

Sperm Cryopreservation (Banking)

Sperm banking before chemotherapy, radiation, vasectomy, or military deployment is strongly recommended. Modern cryopreservation maintains sperm viability for decades. Any man facing a treatment that may compromise future fertility should be offered banking as a standard of care.

The Emotional Journey of ART

ART treatment is physically demanding (for the female partner especially), financially costly, and emotionally exhausting. Multiple cycles are often needed. Miscarriage after IVF is not uncommon. Couples benefit enormously from access to counseling — both to process the grief that can accompany infertility and failed cycles, and to make informed decisions together. Many fertility clinics now include psychological support as part of standard care.

↑ Back to Table of Contents

11. References

  1. WHO — PMID: 35027189 — WHO Laboratory Manual for the Examination and Processing of Human Semen (6th edition). WHO Press. 2021.
  2. Krausz C, Riera-Escamilla A — PMID: 22975981 — Genetics of male infertility. Nat Rev Urol. 2018.
  3. Agarwal A, Mulgund A, Hamada A, Chyatte MR — PMID: 20671018 — A unique view on male infertility around the globe. Reprod Biol Endocrinol. 2015.
  4. Schlegel PN — PMID: 19632553 — Nonobstructive azoospermia: a revolutionary surgical approach and results. Semin Reprod Med. 2009.
  5. Evers JL — PMID: 22420013 — Female subfertility. Lancet. 2002.
  6. Jarow JP, Espeland MA, Lipshultz LI — PMID: 15784937 — Evaluation of the azoospermic patient. J Urol. 1989.
  7. Raheem OA, et al. — PMID: 30545023 — Surgical management of male infertility. Transl Androl Urol. 2019.
  8. Esteves SC, Agarwal A — PMID: 21849071 — Novel concepts in male infertility. Int Braz J Urol. 2011.
  9. Tournaye H, Krausz C, Oates RD — PMID: 25638517 — Concepts in diagnosis and therapy for male reproductive impairment. Lancet Diabetes Endocrinol. 2017.
  10. Plana MN, et al. — PMID: 22078159 — Varicocele and male fertility. Cochrane Database Syst Rev. 2001.
  11. Ferlin A, et al. — PMID: 28412469 — Genetic causes of male infertility. Reprod Toxicol. 2007.
  12. Hamada A, Esteves SC, Nizza M, Agarwal A — PMID: 19878853 — Unexplained male infertility: diagnosis and management. Int Braz J Urol. 2012.

↑ Back to Table of Contents

Connections

↑ Back to Table of Contents